Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
00:54:13 EST Sun 08 Feb 2026
Enter Symbol
or Name
USA
CA



Z:ZTS - ZOETIS INC - https://www.zoetis.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ZTS - Z3.0125.60·130.001.0127.42+0.730.64,127.7525,53031,605127.99  129.95  126.54177.00  115.2519:16:45Feb 0515 min RT 2¢

Recent Trades - Last 10 of 31605
Time ETExPriceChangeVolume
19:16:45Z129.502.775
16:33:06Z127.420.6915
16:27:56Z127.420.6965
16:26:55Z127.000.275
16:20:00Z127.420.691,006
16:15:07Z127.420.691
16:15:07Z127.420.691
16:10:32Z130.003.2710
16:10:05Z127.420.691
16:10:05Z127.420.691

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-02-05 16:15U:ZTSNews ReleaseZoetis Declares Second Quarter 2026 Dividend
2025-12-30 08:30U:ZTSNews ReleaseZoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2025 Financial Results
2025-12-18 08:30U:ZTSNews ReleaseZoetis to Participate in the 44th Annual J.P. Morgan Healthcare Conference
2025-12-16 01:15U:ZTSNews ReleaseZoetis Announces Pricing of $1.75 Billion Convertible Senior Notes Offering
2025-12-15 07:09U:ZTSNews ReleaseZoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering
2025-12-11 16:15U:ZTSNews ReleaseZoetis Declares First Quarter 2026 Dividend; Board Approves 6% Payment Increase
2025-12-05 08:30U:ZTSNews ReleaseZoetis Receives Health Canada Approval for Portela(TM)(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats
2025-12-02 07:30U:ZTSNews ReleaseZoetis Highlights R&D Leadership and Long-Term Growth Opportunity at Innovation Webcast
2025-11-26 16:15U:ZTSNews ReleaseZoetis Receives European Commission Marketing Authorization for Lenivia(TM) (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
2025-11-20 08:30U:ZTSNews ReleaseZoetis to Participate in the Piper Sandler 37th Annual Healthcare Conference
2025-11-19 08:30U:ZTSNews ReleaseZoetis to Host Innovation Webcast
2025-11-04 07:00U:ZTSNews ReleaseZoetis Announces Third Quarter 2025 Results
2025-11-03 16:15U:ZTSNews ReleaseZoetis Announces Retirement of Rob Polzer at the End of 2025 and the Appointment of Kevin Esch as President of Research & Development for World Leader in Animal Health Beginning in 2026
2025-10-29 08:30U:ZTSNews ReleaseZoetis Receives European Commission Marketing Authorization for Portela(TM) (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats
2025-10-28 08:30U:ZTSNews ReleaseZoetis Appoints Stephanie Tilenius to its Board of Directors
2025-10-15 07:00U:ZTSNews ReleaseZoetis Announces Health Canada Approval of Lenivia(TM) (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in Dogs
2025-10-10 16:15U:ZTSNews ReleaseZoetis Receives Positive Opinion from CVMP for Lenivia(TM) (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
2025-10-09 16:15U:ZTSNews ReleaseZoetis Declares Fourth Quarter 2025 Dividend
2025-09-30 16:15U:ZTSNews ReleaseZoetis Receives Conditional Approval for Dectomax(TM)-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle
2025-09-23 08:30U:ZTSNews ReleaseZoetis to Host Webcast and Conference Call on Third Quarter 2025 Financial Results